Help Sitemap Home Skip Navigation Contact Us Disability Statement

The hunt is On.
Sponsored by
Can you track down Scotland's wildest beastie?
 
 
Friday, 5th December 2008

Haggis Hunt is now on!

Premium Article !

Your account has been frozen. For your available options click the below button.

Options

Premium Article !

To read this article in full you must have registered and have a Premium Content Subscription with the Scotland On Sunday site.

Subscribe

Registered Article !

To read this article in full you must be registered with the site.

Drug pricing review is vital for patients



Click on thumbnail to view image
Click on thumbnail to view image
Click on thumbnail to view image
Click on thumbnail to view image
Click on thumbnail to view image

Published Date: 12 October 2008
WHETHER or not cancer patients' expectations are falsely raised by pharmaceutical companies is a key issue highlighted by the current debate on top-ups – and demonstrates how top-ups cannot be considered in isolation ('Cancer patients expect too much from the NHS', October 5).
Breakthrough Breast Cancer does not accept, as chairman of the Scottish Medicines Consortium (SMC) Dr Ken Paterson suggests, that the NHS cannot afford to enable access to clinically effective drug treatments for all patients who could benefit. Drug
costs in Scotland are a modest part of the total cancer care budget. It's crucial the current system of pharmaceutical drug pricing is reviewed to create a greater chance of new, clinically effective treatments becoming available on the NHS for all patients who could benefit from them. In addition, an urgent review of cancer drugs budgets should be undertaken and the NHS should ensure it is making the most efficient and effective use of its resources.

At the same time, it's vital all patients receive realistic and clear information on the benefits, risks and limitations of new treatments, so they can make informed decisions regarding their treatment, and that clinicians are supported in accessing up-to-date information. Equally, healthcare professionals need to be skilled in communicating complex health information.

Breakthrough has consulted extensively with people affected by breast cancer on the issue of top-ups and believes that better communication about the outcomes of the SMC reviews are essential. Quality Adjusted Life Year levels used by the SMC to assess cost effectiveness of treatments must be regularly updated to take into account rising costs and up to date assessments of quality of life measures.

We urge the Scottish Government to ensure its review finds ways of making long-lasting recommendations that will not increase treatment inequalities nor indeed undermine the founding principles of the NHS.

Audrey Birt, director for Scotland, Breakthrough Breast Cancer, London





The full article contains 324 words and appears in Scotland On Sunday newspaper.
Page 1 of 1

  • Last Updated: 11 October 2008 8:41 PM
  • Source: Scotland On Sunday
  • Location: Scotland
 
 

Comment on this Story

 

In order to post comments you must Register or Sign In

 
 
 
  

 
 


Sister Newspapers:
Press Complaints Commission

This website and its associated newspaper adheres to the Press Complaints Commission’s Code of Practice. If you have a complaint about editorial content which relates to inaccuracy or intrusion, then contact the Editor by clicking here.

If you remain dissatisfied with the response provided then you can contact the PCC by clicking here.